38 Clinicopathological Risk Factors, Poorly Stratified Baseline Risk, and RT Benefit Compared to DCISionRT in Patients With Ductal Carcinoma in Situ

Publication
Article
Miami Breast Cancer Conference® Abstracts Supplement39th Annual Miami Breast Cancer Conference® - Abstracts
Volume 36
Issue suppl 3
Pages: 27

Objective

Over- and undertreatment of ductal carcinoma in situ (DCIS) has been a persistent clinical problem with traditional clinicopathologic features unable to stratify patients appropriately. DCISionRT reports a decision score (DS) validated in multiple cohorts, including the randomized SweDCIS Trial, which is prognostic for 10-year ipsilateral breast recurrence (IBR) risk after breast-conserving surgery (BCS) and predictive for radiotherapy (RT) benefit. Here, stratification of IBR risk and RT benefit by clinicopathology was assessed with DCISionRT.


Methods

DCISionRT and its integrated residual risk subtype (RRt) was evaluated in 493 patients from 3 cohorts at a Clinical Laboratory Improvement Amendments (CLIA) lab (PreludeDx, Laguna Hills, CA) who were treated with BCS or BCS plus RT. Clinicopathology features were analyzed in a multivariable analysis with DCISionRT and its integrated RRt-classified risk groups for 10-year IBR.


Results

The biosignature classified patients into low (DS ≤ 2.8, n = 173), elevated (DS > 2.8 without RRt, n = 209), and residual (DS > 2.8 with RRt, n = 111) risk groups. Patients had increased 10-year rates of IBR risk in the elevated (21.4%, P <.001) and residual (43.4%, P <.001) risk groups without RT, and benefited from RT (elevated: HR, 0.15, P = .002; residual: HR, 0.27, P = .004) versus the low-risk group (5.5%; HR, 1.28; P = .7). The residual versus elevated risk group had an increased 10-year IBR risk rate after RT (20.5% vs 3.2%, P = .008). Clinicopathologic features (age, grade, size, palpability, and necrosis) were not associated with the 10-year IBR risk rate in multivariable analysis including DCISionRT and treatment. The distribution of clinicopathologic features varied between biosignature risk groups; the residual risk group had a higher proportion of patients with nuclear grade 3 (71% vs 31%, P < .001), necrosis (89% vs 56%, P < .001), and size greater than 1 cm (54% vs 35%, P < .001) when compared with low- and elevated- risk groups, but no significant change was noted in the distribution between DCISionRT risk groups for age.


Conclusions

DCISionRT classified patients into 3 groups with distinct risk and RT benefit profiles, where the residual risk group had the highest 10-year IBR risk rate without RT and significantly elevated IBR risk after RT. The distribution of clinicopathological features varied between biosignature risk groups but were not significantly associated with the 10-year IBR risk rate, accounting for DCISionRT risk groups and treatment.

Author Affiliations:

Pat W. Whitworth,1 Rachel Rabinovitch,2 Frank A. Vicini,3 Chirag Shah,4 Fredrik Wärnberg,5 G. Bruce Mann,6 Steven C. Shivers,7 Karuna Mittal,7 Troy Bremer,7

1Nashville Breast Center, Nashville, TN
2University of Colorado, Colorado Springs, CO 3GenesisCare, Farmington Hills, MI
4Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

5Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
6University of Melbourne, Melbourne, Australia

7PreludeDx, Laguna Hills, CA

Articles in this issue

15 COVID-19 Disease Course in Immunocompetent and Immunocompromised Patients  in a Breast Cancer Registry
15 COVID-19 Disease Course in Immunocompetent and Immunocompromised Patients in a Breast Cancer Registry
37 The Routine Use of Bioimpedance Spectroscopy Measurements in the Clinic as a Surrogate for Bone Mineral Content in Oncology Patients: Practical Application of the SOZO Device
37 The Routine Use of Bioimpedance Spectroscopy Measurements in the Clinic as a Surrogate for Bone Mineral Content in Oncology Patients: Practical Application of the SOZO Device
18 Psychosocial Wellbeing and Health Care Resource Utilization Among Patients With Breast Cancer During COVID-19
18 Psychosocial Wellbeing and Health Care Resource Utilization Among Patients With Breast Cancer During COVID-19
43 Early Detection of Breast Cancer–Related Lymphedema: Accuracy of Indocyanine Green Lymphography Compared With Bioimpedance Spectroscopy  and Symptoms
43 Early Detection of Breast Cancer–Related Lymphedema: Accuracy of Indocyanine Green Lymphography Compared With Bioimpedance Spectroscopy and Symptoms
3 Frequency of Germline Variants in Breast Cancer Predisposing Genes: Genetic Background of Brazilian Women With Breast Cancer
3 Frequency of Germline Variants in Breast Cancer Predisposing Genes: Genetic Background of Brazilian Women With Breast Cancer
44 Implementation of a Novel Radiopaque Filament Marker at a Single Breast Cancer Surgery Center
44 Implementation of a Novel Radiopaque Filament Marker at a Single Breast Cancer Surgery Center
39TiP The PREDICT Registry: A Prospective Registry Study to Evaluate the Effect of a Predictive Assay on Treatment Decisions in Patients withDCIS Following Breast Conserving Therapy
39TiP The PREDICT Registry: A Prospective Registry Study to Evaluate the Effect of a Predictive Assay on Treatment Decisions in Patients withDCIS Following Breast Conserving Therapy
38 Clinicopathological Risk Factors, Poorly Stratified Baseline Risk, and RT Benefit Compared to DCISionRT in Patients With Ductal Carcinoma in Situ
38 Clinicopathological Risk Factors, Poorly Stratified Baseline Risk, and RT Benefit Compared to DCISionRT in Patients With Ductal Carcinoma in Situ
28 Case Series: Imaging Appearance of Non–Breast Cancer Solid Masses in the Male Breast
28 Case Series: Imaging Appearance of Non–Breast Cancer Solid Masses in the Male Breast
20 Evaluating Number, Age, and Radiographic BIRADS of Patients Visiting Mammography Unit in Baghdad, Iraq, in 2019, 2020, and 2021: A Retrospective Study
20 Evaluating Number, Age, and Radiographic BIRADS of Patients Visiting Mammography Unit in Baghdad, Iraq, in 2019, 2020, and 2021: A Retrospective Study
5 Feasibility of WF-OCT as an Adjunct to Intraoperative Specimen X-ray for Breast Conservation Surgical Specimens
5 Feasibility of WF-OCT as an Adjunct to Intraoperative Specimen X-ray for Breast Conservation Surgical Specimens
41 A Single-Centre Report on the Upgrade Rate of Complex Sclerosing Lesions of the Breast
41 A Single-Centre Report on the Upgrade Rate of Complex Sclerosing Lesions of the Breast
45 The Informed Consent Experience for Breast Cancer Surgery and Its Association With Patient Satisfaction
45 The Informed Consent Experience for Breast Cancer Surgery and Its Association With Patient Satisfaction
29 The Effect of Personality Type on Satisfaction With Information Exchange in Breast Cancer Patients
29 The Effect of Personality Type on Satisfaction With Information Exchange in Breast Cancer Patients
36 Are Positive Margins in DCIS a True Indication of Inadequate Surgery?
36 Are Positive Margins in DCIS a True Indication of Inadequate Surgery?